All lobbying filings

CROSSROADS STRATEGIES, LLC

Lobbying for HALEON US HOLDINGS LLC · consumer health care company

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 20, 2025

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025

Lobbying activity 3

Health Issues

Issues related to healthcare and payment for over-the-counter drugs; General education of over-the-counter switches, including reauthorization of the Over-the-Counter Monograph Drug User Fee Act and policies impacting a Nonprescription Drug Product with an Additional Condition for Nonprescription Use.

Taxation/Internal Revenue Code

Issues related to coverage of over-the-counter products with FSAs and HSAs; H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (P.L.119-4).

Budget/Appropriations

Policies impacting access to over-the-counter products; H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (P.L.119-4).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.